Journal article

Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: A psychophysiological study

Rubio-Aurioles E, Lopez M, Lipezker M, Lara C, Ram??rez A, Rampazzo C, Hurtado De Mendoza M, Lowrey F, Loehr L, Lammers P ...see all

Journal of Sex and Marital Therapy, vol. 28, issue SUPPL. 1 (2002) pp. 205-215

  • 9


    Mendeley users who have this article in their library.
  • 35


    Citations of this article.
Sign in to save reference


The objective of this study was to assess the potential of phentolamine as a treatment of postmenopausal women with female arousal disorder (FSAD). Vaginal photoplethismography and a subjective questionnaire were used. Forty one women were enrolled and four treatments were tested: vaginal solutions 5 mg and 40 mg and an oral tablet each of 40 mg of phentolamine and placebo. Physiological readings were significantly different from placebo in the women using hormone replacement therapy (HRT) with 40 mg of phentolamine in vaginal solution (p = 0.0186). Subjective reports also were significantly different from placebo with the vaginal solution 40 mg and the oral tablet of 40 mg of phentolamine among hormone replacement users. No significant differences were found among women not receiving HRT. Results indicate that phentolamine may show promise as treatment for FSAD in estrogenized postmenopausal women.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Eusebio Rubio-Aurioles

  • Marcela Lopez

  • Mirtha Lipezker

  • Claudia Lara

  • Abraham Ram??rez

  • Claudia Rampazzo

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free